Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
T. Rowe Price Associates Inc's stake in Bridgebio Oncology Therapeutics, Inc. fell to 1.10% (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
T. Rowe Price Associates Inc's stake in Bridgebio Oncology Therapeutics, Inc. fell to 1.10%, 885,042 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 1.10%
- Shares
- 885,042
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 1.10% | 885,042 |